⌘K

Home/Filings/4/0000878088-10-000022

4//SEC Filing

PAR PHARMACEUTICAL COMPANIES, INC. 4

Accession 0000878088-10-000022

CIK 0000878088operating

View on SEC.gov Company Profile

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 6:25 PM ET

Size

34.0 KB

Accession

0000878088-10-000022

Insider Transaction Report

Form 4

Period: 2010-03-03

PAR PHARMACEUTICAL COMPANIES, INC.PRX

KENYON LAWRENCE A

EVP, Chief Financial Officer

Transactions

Sale
Common Stock
2010-03-03$25.19/sh−700$17,631→ 38,127 total
Sale
Common Stock
2010-03-03$25.21/sh−200$5,043→ 25,975 total
Sale
Common Stock
2010-03-03$25.18/sh−3,261$82,128→ 38,827 total
Sale
Common Stock
2010-03-03$25.20/sh−500$12,598→ 32,916 total
Sale
Common Stock
2010-03-03$25.21/sh−1,041$26,244→ 26,175 total
Sale
Common Stock
2010-03-03$25.22/sh−3,426$86,404→ 22,349 total
Sale
Common Stock
2010-03-03$25.24/sh−100$2,524→ 22,249 total
Sale
Common Stock
2010-03-03$25.26/sh−400$10,104→ 21,149 total
Sale
Common Stock
2010-03-03$25.21/sh−100$2,521→ 27,216 total
Exercise/Conversion
Common Stock, Option to Buy
2010-03-03−21,439→ 64,319 total
Exercise: $13.06Exp: 2019-01-07→ Common Stock (21,439 underlying)
Exercise/Conversion
Common Stock
2010-03-03$13.06/sh+21,439$279,993→ 42,088 total
Sale
Common Stock
2010-03-03$25.25/sh−100$2,525→ 22,149 total
Sale
Common Stock
2010-03-03$25.19/sh−4,711$118,670→ 33,416 total
Sale
Common Stock
2010-03-03$25.20/sh−2,800$70,560→ 30,116 total
Sale
Common Stock
2010-03-03$25.20/sh−2,700$68,054→ 27,416 total
Sale
Common Stock
2010-03-03$25.21/sh−100$2,521→ 27,316 total
Sale
Common Stock
2010-03-03$25.22/sh−200$5,043→ 25,775 total
Sale
Common Stock
2010-03-03$25.25/sh−600$15,153→ 21,549 total
Sale
Common Stock
2010-03-03$25.27/sh−300$7,580→ 20,849 total
Sale
Common Stock
2010-03-03$25.27/sh−200$5,054→ 20,649 total

Footnotes (2)

[F1]Represents all shares of Restricted Stock held by Mr. Kenyon
[F2]Mr. Kenyon was granted an option to purchase 85,758 shares of Common Stock under the Company's 2004 Performance Equity Plan. 25% (21,439 shares) vested on 1/8/2010 (the first anniversary of the date of grant); an additional 25% vest on each anniversary thereafter until vested.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

PAR PHARMACEUTICAL COMPANIES, INC.

CIK 0000878088

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000878088

Filing Metadata

Form type: 4
Filed: Mar 2, 7:00 PM ET
Accepted: Mar 3, 6:25 PM ET
Size: 34.0 KB

View on SEC.gov